Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
更正：RAS/MAPK通路激活赋予急性髓系白血病细胞MCL-1介导的对BCL-2抑制剂维奈托克的获得性耐药性。
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-022-00958-4
Zhang, Qi; Riley-Gillis, Bridget; Han, Lina; Jia, Yannan; Lodi, Alessia; Zhang, Haijiao; Ganesan, Saravanan; Pan, Rongqing; Konoplev, Sergej N; Sweeney, Shannon R; Ryan, Jeremy A; Jitkova, Yulia; Dunner, Kenneth Jr; Grosskurth, Shaun E; Vijay, Priyanka; Ghosh, Sujana; Lu, Charles; Ma, Wencai; Kurtz, Stephen; Ruvolo, Vivian R; Ma, Helen; Weng, Connie C; Ramage, Cassandra L; Baran, Natalia; Shi, Ce; Cai, Tianyu; Davis, Richard Eric; Battula, Venkata L; Mi, Yingchang; Wang, Jing; DiNardo, Courtney D; Andreeff, Michael; Tyner, Jeffery W; Schimmer, Aaron; Letai, Anthony; Padua, Rose Ann; Bueso-Ramos, Carlos E; Tiziani, Stefano; Leverson, Joel; Popovic, Relja; Konopleva, Marina
